Skip to main content
. Author manuscript; available in PMC: 2014 Sep 25.
Published in final edited form as: Leuk Res. 2013 Mar 23;37(7):795–801. doi: 10.1016/j.leukres.2013.03.001

Table 4.

Survival of patients known to have relapsed.

Late N = 9 Early All patients N = 103 ATRA anytimea N = 60
Alive after relapse, N (%) 7 (78%) 35 (34%) 22 (37%)
Follow-up of known to be alive, yrs.
Median
Range 17.7 11.5 11.5
7.7–18.4 0.7–14 8.3–14
Overall survival after CR1, yrs.
Median NR 2.1 2.5
95% Confidence intervals 3.3, ∞ 1.7, 3.4 1.6, 5.3
a

Early ATRA anytime– patients who received ATRA at any time (induction, maintenance or both).